The UCSF Rosenman Institute provides startups with expertise and mentor-ship from stakeholders across the healthcare industry. The Institute is inviting (40) startups to pitch on May 4 or 5 to a panel of judges comprised of financial/strategic investors, subject matter experts, and clinicians. The judges will select (10) startups as the 2021 Rosenman Innovators.

If selected, your startup will:

  • Receive coaching in communications, product development, IP, clinical/regulatory, reimbursement, marketing and business strategy from our network of experts.
  • Present to a select group of investors and industry partners.
  • Showcase your startup at the high-profile Rosenman Symposium on June 10, 2021.
  • Be eligible to receive a range of valuable in-kind services to help you accelerate your technology.

Who Can Apply?

Early-stage health technology companies (up to and including Series A investment) based in California, or with a senior leadership position based in California. No university affiliation is required. If you have applied in previous years but not been chosen for the final cohort, we welcome you to apply again if your startup has made progress.

How Can I be Selected for In-Kind Services?

Our participating partners will choose the recipients of their services from among the (10) Rosenman Innovators. Services include prototyping, IP strategy, pre-clinical studies, regulatory, reimbursement consultation, and more. Criteria for matching a startup to a particular service include technology, market potential, and how much the startup would benefit. Learn more at

What Are the Key 2021 Dates?

April 12: Deadline to apply.

April 22: First round of selection: qualified startups notified.

April 27: Executive communications coaching session for startups selected in first round.

May 4 and 5: Startups present to judging panel at the UCSF Mission Bay campus.

May 10: Startups selected as Rosenman Innovators notified.

May 12-June 9: Selected companies meet with executive advisors

May 24-25: Communications Coaching Individual Sessions.

June 10: Innovators pitch investors & partners in private session.

To learn more and apply, visit

For additional information contact Christine Winoto at 415-514-9430, Christine is the Director of the UCSF Rosenman Institute and Founding Partner of MedTech Venture Partners I, LLP.


About Rowinski Group

Founded in 2004, Rowinski Group LLC is a reimbursement and healthcare payer data analytics consultancy for medical device, digital health and diagnostics companies. Rowinski Group is based in Silicon Valley – San Francisco bay area with offices at selected client locations.

Rowinski Group has two core service offerings; securing codes and reimbursement on behalf of companies and applying healthcare payer data analytics to help solve companies’ complex business issues such as responding to questions from the FDA and Medicare. For more information visit

Certified WBENC Pantone w k textRowinski Group is a nationally certified as a Women’s Business Enterprise (WBE). The WBE certification is relevant for companies and government agencies who use supplier diversity programs to award contracted services.